Your session is about to expire
← Back to Search
Behavioral Intervention
Computerized Education for Kidney Disease (ICCKD Trial)
N/A
Recruiting
Led By Milda Saunders, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 day post-intervention and 30 day follow-up
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test if a personalized computer education program can improve understanding and interest in self-care for kidney disease in African-American patients. It compares this program to standard care to see if it makes a
Who is the study for?
This trial is for hospitalized African-American patients with advanced chronic kidney disease (CKD), including those with high blood pressure. The study focuses on evaluating a computerized education program tailored to their cultural needs.
What is being tested?
The study compares two approaches: a culturally tailored computerized CKD education program versus the usual hospital care. It aims to see if the new method improves knowledge and intent for self-care and preparation for renal replacement therapy.
What are the potential side effects?
Since this trial involves an educational intervention, there are no direct medical side effects like you'd expect from medication or surgery. However, participants may experience stress or fatigue from engaging with the material.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1 day post-intervention and 30 day follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 day post-intervention and 30 day follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in CKD Knowledge baseline to post patient education intervention
Change in ESKD Treatment Preferences from baseline to 1 day post-intervention
Change in Knowledge about end stage kidney disease (ESKD) treatments from baseline to 1 day post patient education intervention
Secondary study objectives
CKD Self-Management from baseline to 30 day post-intervention
Change in Patient Activation Measure from Baseline to 30 days Post-intervention
Increase in Health Intent baseline to post intervention (at 1 day and 30 day follow-up)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Computerized Patient EducationExperimental Treatment1 Intervention
The RA will assist participants in starting the computer program and encourage review of the advanced CKD education module. The computer-adaptive education module will alter the content of education topics based on some preliminary participant information.
Group II: Usual CareActive Control1 Intervention
The research assistant (RA) will use tablet to give participants baseline General Health Knowledge and Intent survey and leave printed patient education materials about general health maintenance. In the initial consent, pre-intervention survey and education materials, investigators will not provide CKD specific knowledge or inform participants about their CKD.
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,062 Previous Clinical Trials
840,016 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,463 Previous Clinical Trials
4,337,283 Total Patients Enrolled
Milda Saunders, MDPrincipal InvestigatorAssociate Professor of Medicine